Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Total-Revenue" stands at 45.93 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 13.17 Billion EUR for the item "Total Revenue" represents an increase of 22.68 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 13.17 Billion EUR for the item "Total Revenue" represents a decrease of -6.97 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 45.93 Billion EUR for the item "Total Revenue" represents a decrease of -2.10 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.27 percent compared to the value the year prior.
The 1 year change in percent is 12.27.
The 3 year change in percent is 3.57.
The 5 year change in percent is 21.99.
The 10 year change in percent is 36.20.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Revenue | 280,205,508,085.11 |